Literature DB >> 19596509

Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder.

Christian Bolenz, Yair Lotan, Raheela Ashfaq, Shahrokh F Shariat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19596509     DOI： 10.1016/j.eururo.2009.06.032

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  26 in total

Review 1.  Biomolecular predictors of urothelial cancer behavior and treatment outcomes.

Authors:  Michael Rink; Eugene K Cha; David Green; Jens Hansen; Brian D Robinson; Yair Lotan; Arthur I Sagalowsky; Felix K Chun; Pierre I Karakiewicz; Margit Fisch; Douglas S Scherr; Shahrokh F Shariat
Journal:  Curr Urol Rep       Date:  2012-04       Impact factor: 3.092

2.  Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract.

Authors:  Eiji Kashiwagi; Kazutoshi Fujita; Seiji Yamaguchi; Hiroaki Fushimi; Hiroki Ide; Satoshi Inoue; Taichi Mizushima; Leonardo O Reis; Rajni Sharma; George J Netto; Norio Nonomura; Hiroshi Miyamoto
Journal:  Cancer Biol Ther       Date:  2016-09-16       Impact factor: 4.742

Review 3.  Impact of gender on bladder cancer incidence, staging, and prognosis.

Authors:  Harun Fajkovic; Joshua A Halpern; Eugene K Cha; Atessa Bahadori; Thomas F Chromecki; Pierre I Karakiewicz; Eckart Breinl; Axel S Merseburger; Shahrokh F Shariat
Journal:  World J Urol       Date:  2011-06-09       Impact factor: 4.226

4.  Gender effect on the oncologic outcomes of upper urinary tract urothelial carcinoma in Taiwan.

Authors:  Yen-Ting Wu; Hao Lun Luo; Hung Jen Wang; Yen Ta Chen; Yuan Tso Cheng; Po Hui Chiang
Journal:  Int Urol Nephrol       Date:  2020-01-29       Impact factor: 2.370

5.  Immunohistochemical analysis of sex hormone receptors in squamous changes of the urothelium.

Authors:  Julia B Seitz; Josef Högel; Markus Eckstein; Verena Lieb; Bernd Wullich; Arndt Hartmann; Ralf J Rieker
Journal:  Int J Clin Exp Pathol       Date:  2022-07-15

6.  Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy.

Authors:  Bastian Keck; Oliver J Ott; Lothar Häberle; Frank Kunath; Christian Weiss; Claus Rödel; Rolf Sauer; Rainer Fietkau; Bernd Wullich; Frens S Krause
Journal:  World J Urol       Date:  2012-10-23       Impact factor: 4.226

Review 7.  Role of oestrogen receptors in bladder cancer development.

Authors:  Iawen Hsu; Spencer Vitkus; Jun Da; Shuyuan Yeh
Journal:  Nat Rev Urol       Date:  2013-04-16       Impact factor: 14.432

8.  The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer.

Authors:  Zaixian Zhang; Qingquan Xu; Xiaobo Huang; Jia Yang; Yanhong Xu; Guixiang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 9.  Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity.

Authors:  Georgios Gakis; Arnulf Stenzl
Journal:  World J Urol       Date:  2013-02-09       Impact factor: 4.226

10.  Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

Authors:  Suraj Konnath George; Veronica Tovar-Sepulveda; Steven S Shen; Weiguo Jian; Yiqun Zhang; Susan G Hilsenbeck; Seth P Lerner; Carolyn L Smith
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.